BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21079778)

  • 1. Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.
    Lessi F; Beggs A; de Palo M; Anti M; Macarone Palmieri R; Francesconi S; Gomes V; Bevilacqua G; Tomlinson I; Segditsas S
    PLoS One; 2010 Nov; 5(11):e13840. PubMed ID: 21079778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.
    Suh ER; Ha CS; Rankin EB; Toyota M; Traber PG
    J Biol Chem; 2002 Sep; 277(39):35795-800. PubMed ID: 12124393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.
    Shaffer JM; Smithgall TE
    Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
    Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
    Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
    Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
    Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.
    You Y; Yang W; Wang Z; Zhu H; Li H; Lin C; Ran Y
    Cell Oncol (Dordr); 2013 Jul; 36(4):323-31. PubMed ID: 23740091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
    Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; JagodziƄski PP
    BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells.
    Ren JZ; Huo JR
    Med Oncol; 2012 Jun; 29(2):915-8. PubMed ID: 21298366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
    Deng G; Song GA; Pong E; Sleisenger M; Kim YS
    Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.
    Greco SA; Chia J; Inglis KJ; Cozzi SJ; Ramsnes I; Buttenshaw RL; Spring KJ; Boyle GM; Worthley DL; Leggett BA; Whitehall VL
    BMC Cancer; 2010 Sep; 10():494. PubMed ID: 20846368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.